PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2204-2211

  Johnson, Raymond M ^a   Yu, Hong ^b   Kerr, Micah S ^a   Slaven, James E ^a   Karunakaran, Karuna P ^b   Brunham, Robert C ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; CD4 ANTIGEN; CHLAMYDIA ANTIGEN; EPITOPE; GAMMA INTERFERON; PMPG 1 PROTEIN DERIVATIVE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; OUTER MEMBRANE PROTEIN; PMPG PROTEIN, CHLAMYDIA TRACHOMATIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE DURATION; EPITHELIUM CELL; FEMALE; GENITAL TRACT INFECTION; IRRADIATION; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; EPITHELIAL CELLS; EPITOPES; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL;

EID: 85047686844     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06339-11     Document Type: Article

References (32)

1. Appay V, et al. 2002. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168:5954 -5958.
2. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. 2005. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J. Infect. Dis. 192:1836 -1844.
3. Brunham RC, Rekart ML. 2008. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex. Transm. Dis. 35:53-54.
4. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65:2145-2152.
5. Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727-738.
6. Duc HT, Rucay P, Righenzi S, Halle-Pannenko O, Kourilsky P. 1993. Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens. Int. Immunol. 5:427- 431.
7. He Q, et al. 2005. Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response. J. Immunol. 174:4860-4869.
8. Igietseme JU, et al. 1998. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 66:1282-1286.
9. Igietseme JU, Wyrick PB, Goyeau D, Rank RG. 1994. An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect. Immun. 62:3528 -3535.
10. Jayarapu K, Kerr M, Ofner S, Johnson RM. 2010. Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms. J. Immunol. 185:6911- 6920.
11. Jayarapu K, Kerr MS, Katschke A, Johnson RM. 2009. Chlamydia muridarum-specific CD4 T-cell clones recognize infected reproductive tract epithelial cells in an interferon-dependent fashion. Infect. Immun. 77:4469-4479.
12. Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. 2008. Characterization of murine dendritic cell line JAWS II and primary bone marrowderived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect. Immun. 76:2392-2401.
13. Johnson RM. 2004. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect. Immun. 72:3951-3960.
14. Karunakaran KP, et al. 2008. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J. Immunol. 180:2459-2465.
15. Krogsgaard M, et al. 2000. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibodyspecific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191:1395-1412.
16. Moore T, et al. 2002. Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105:213-221.
17. Moore T, et al. 2003. Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J. Infect. Dis. 188:617-624.
18. Morrison RP, Caldwell HD. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70:2741-2751.
19. Morrison RP, Feilzer K, Tumas DB. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class IIrestricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661- 4668.
20. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. 2001. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect. Immun. 69: 5131-5137.
21. Ramsey KH, Soderberg LS, Rank RG. 1988. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 56:1320 -1325.
22. Reeves DM, Nagarajan U, O'Connell C, Andrews CW, Jr, Darville T. 2007. Lack of an effect of antibiotic treatment on prolonged detection of chlamydial DNA in murine genital tract infection. Antimicrob. Agents Chemother. 51:2646 -2648.
23. Rekart ML, Brunham RC. 2008. Epidemiology of chlamydial infection: are we losing ground? Sex. Transm. Infect. 84:87-91.
24. Rock KL, Benacerraf B, Abbas AK. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160:1102-1113.
25. Schachter J (ed). 1980. Chlamydiae (Psittacosis-lymphogranuloma venereum-trachoma group), 3rd ed. American Society for Microbiology, Washington, DC.
26. Su H, Caldwell HD. 1995. CD4+T cells play a significant role in adaptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63:3302-3308.
27. Su H, Feilzer K, Caldwell HD, Morrison RP. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65:1993-1999.
28. Su H, et al. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 188:809-818.
29. Tanaka K. 1994. Role of proteasomes modified by interferon-gamma in antigen processing. J. Leukoc. Biol. 56:571-575.
30. Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC. 2009. Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models. J. Immunol. 182:1602-1608.
31. Yu H, et al. 2010. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells. Infect. Immun. 78:2272-2282.
32. Yu H, et al. 2011. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation withMHCclass II peptide presentation and multifunctional Th1 cells. J. Immunol. 186:3615-3621.